Qualigen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
08. September 2021 07:30 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with...
ProPhase Labs to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
07. September 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Sept. 07, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
Cocrystal Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
07. September 2021 08:00 ET
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company, announces that management will...